These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12297124)

  • 1. Antiplatelet activity of semotiadil fumarate.
    Wolfram RM; Kritz H; Oguogho A; Sinzinger H
    Thromb Res; 2002 May; 106(4-5):187-90. PubMed ID: 12297124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of semotiadil, a novel Ca2+ channel antagonist, on the electrical activity of Langendorff-perfused guinea pig hearts in comparison with diltiazem, amlodipine and nifedipine.
    Stark G; Kasper K; Stark U; Miyawaki N; Decrinis M; Tritthart HA
    Eur J Pharmacol; 1995 Nov; 286(1):71-8. PubMed ID: 8566153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel benzothiazine Ca2+ channel antagonist, semotiadil, inhibits cardiac L-type Ca2+ currents.
    Koidl B; Miyawaki N; Tritthart HA
    Eur J Pharmacol; 1997 Mar; 322(2-3):243-7. PubMed ID: 9098694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
    Glusa E; Bevan J; Heptinstall S
    Thromb Res; 1989 Jul; 55(2):239-245. PubMed ID: 2528843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of semotiadil fumarate, a novel calcium antagonist, on blood pressure and heart rate in conscious spontaneously hypertensive rats.
    Kanda A; Hashimoto H
    Jpn J Pharmacol; 1993 Sep; 63(1):121-4. PubMed ID: 8271524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
    Kiyomoto A; Sasaki Y; Odawara A; Morita T
    Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model.
    Mori T; Ishigai Y; Fukuzawa A; Chiba K; Shibano T
    Br J Pharmacol; 1995 Sep; 116(1):1668-72. PubMed ID: 8564235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation.
    Yamada Y; Furui H; Furumichi T; Suzuki T; Yamauchi K; Yokota M; Hayashi H; Saito H
    Jpn Heart J; 1990 Mar; 31(2):201-15. PubMed ID: 2113109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of diltiazem and aspirin on platelet aggregation in cats.
    Behrend EN; Grauer GF; Greco DS; Rose BJ; Thrall MA
    J Am Anim Hosp Assoc; 1996; 32(1):11-8. PubMed ID: 8963730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
    Onoda JM; Sloane BF; Honn KV
    Thromb Res; 1984 Jun; 34(5):367-78. PubMed ID: 6377570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiaggregatory activity of N-methyl- and N-isobutyl-1,2-diphenyl ethanolamines in rat platelets.
    el Tahir KE; el-Naser MA; Ageel AM; el-Obeid HA; al-Rashood KA
    Arch Int Pharmacodyn Ther; 1990; 307():162-71. PubMed ID: 2095711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of semotiadil fumarate (SD-3211) and its enantiomer, SD-3212, on the changes in cytosolic Ca2+ and tension caused by KCl and norepinephrine in isolated rat aortas.
    Murakami K; Shindo K; Ito KM; Ito K
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):262-7. PubMed ID: 7752651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
    Ono H; Kimura M
    Arzneimittelforschung; 1981; 31(7):1131-4. PubMed ID: 7196762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers.
    Moore JB; Fuller BL; Falotico R; Tolman EL
    Thromb Res; 1985 Nov; 40(3):401-11. PubMed ID: 2417362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diltiazem and verapamil on ADP-induced rabbit platelet shape change and aggregation.
    Dehpour AR; Samadian T; Akhavan MM; Meysamee F; Delfan A
    Gen Pharmacol; 1995 Oct; 26(6):1295-9. PubMed ID: 7590122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semotiadil, a new calcium antagonist, is a very potent inhibitor of LDL-oxidation.
    Kritz H; Oguogho A; Aghajanian AA; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 1999 Sep; 61(3):183-8. PubMed ID: 10582658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.
    Ware JA; Johnson PC; Smith M; Salzman EW
    Circ Res; 1986 Jul; 59(1):39-42. PubMed ID: 3089642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
    Alarayyed NA; Cooper MB; Prichard BN; Betteridge DJ; Smith CC
    Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of ginger and nifedipine on human platelet aggregation: a study in hypertensive patients and normal volunteers.
    Young HY; Liao JC; Chang YS; Luo YL; Lu MC; Peng WH
    Am J Chin Med; 2006; 34(4):545-51. PubMed ID: 16883626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of the calcium antagonist amlodipine on blood pressure and platelet aggregation in hypertensive patients.
    Hernández R; Carvajal AR; Armas-de Hernández MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragán O; Machado-de Alvarado I
    Postgrad Med J; 1991; 67 Suppl 5():S38-40. PubMed ID: 1839438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.